The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy
| Image |  |
|---|---|
| Description | scientific article published on 20 January 2010 |
| Author/s | |
| Publication date | January 20, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |